Fool.com
Investors Helping Investors Beat the Market
Results 81 - 90 of 202 : Previous 5 6 7 8 9 10 11 12 13 Next
Foolish Forecast: Robots on the Cheap
Views you can use to get clues on tomorrow's news.
Abbott's Stents Aren't (That) Important
Focus on what really matters.
Too Little Too Late for Boston Scientific
The company gets new stent approved, but it should have happened earlier.
Will Johnson & Johnson Ever Get Its Money?
Boston Scientific and Medtronic owe the company money, but will they pay up?
Drugs are just as good as stents.
Bristol-Myers Puts Icahn and ImClone to the Test
Bristol and Icahn both go hostile toward each other.
Medical Device Makers Throwing Money Down the Tube
Congress is investigating medical device maker's direct-to-consumer ads.
4-Star Stocks Poised to Pop: Medtronic
This stock could bring market-beating returns.
Will exchange-traded funds put mutual funds out of business?
Stent Makers Getting Desperate
When competition increases, a company's got to do something.
Results 81 - 90 of 202 : Previous 5 6 7 8 9 10 11 12 13 Next
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK